Our Labs

The Bogetz Lab focuses on improving serious illness care for children with severe neurological impairment and their families through interventions to promote high quality communication and family-centered care.

 The Diekema Lab focuses on ethical issues that affect children in the clinical, research, and policy arenas. Areas of focus have included the limits of parental decision-making on behalf of children, vaccine hesitancy, allocation of limited resources, and issues arising during disasters and pandemics.

The Kett Lab’s primary research interest is communication and medical decision-making with the families of sick children and with NICU families in particular.

The Kraft Lab aims to improve equitable and respectful research for all patients and families.

Our lab focuses on understanding the ethical and social impacts of advances in neuroscience on children and families affected by neurodevelopmental, neurological and psychiatric disorders.

 The Montenegro Lab focuses on examining and addressing bias in medicine.

The Opel Lab focuses on clinician-parent communication and medical decision-making, with a primary goal to improve child health by identifying effective clinician communication strategies that positively influence parent acceptance of recommended interventions for children.

The Trowbridge Lab focuses on improving palliative care access and delivery for patients from diverse backgrounds and teaching primary palliative care and communication skills to health professionals at all levels.  

The Vo Lab focuses on improving health equity and comprehensive care for the chronically ill child.

The Weiss lab focuses on research ethics, with a particular interest in neonatal clinical trials.

The Wightman Lab focuses on research on medical decision-making for children with complex, chronic medical conditions.

The Wilfond Lab seeks better to improve people’s experiences navigating our social institutions and  systems for providing health care and conducting clinical research and focus on ethical and policy issues related to disabilities, genetics, and clinical research.